147 related articles for article (PubMed ID: 21041973)
1. Association between fibroblast growth factor 23 and left ventricular hypertrophy in maintenance hemodialysis patients. Comparison with B-type natriuretic peptide and cardiac troponin T.
Negishi K; Kobayashi M; Ochiai I; Yamazaki Y; Hasegawa H; Yamashita T; Shimizu T; Kasama S; Kurabayashi M
Circ J; 2010 Nov; 74(12):2734-40. PubMed ID: 21041973
[TBL] [Abstract][Full Text] [Related]
2. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
Unver S; Kavlak E; Gümüsel HK; Celikbilek F; Esertas K; Muftuoglu T; Kirilmaz A
Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798
[TBL] [Abstract][Full Text] [Related]
3. The value of serum FGF-23 as a cardiovascular marker in HD patients.
Sany D; Elsawy AE; Aziz A; Elshahawy Y; Ahmed H; Aref H; El Rahman MA
Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):44-52. PubMed ID: 24434381
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 23 and left ventricular mass index in maintenance hemodialysis patients: standard versus long nocturnal hemodialysis.
Knap B; Večerić-Haler Ž; Benedik M; Buturović-Ponikvar J; Ponikvar R; Bren AF
Ther Apher Dial; 2013 Aug; 17(4):407-11. PubMed ID: 23931880
[TBL] [Abstract][Full Text] [Related]
5. Association between hippuric acid and left ventricular hypertrophy in maintenance hemodialysis patients.
Yu TH; Tang WH; Lu YC; Wang CP; Hung WC; Wu CC; Tsai IT; Chung FM; Houng JY; Lan WC; Lee YJ
Clin Chim Acta; 2018 Sep; 484():47-51. PubMed ID: 29758204
[TBL] [Abstract][Full Text] [Related]
6. Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable hemodialysis patients.
Choi SY; Lee JE; Jang EH; Kim MO; Baek H; Ki CS; Park SW; Kim DJ; Huh WS; Oh HY; Kim YG
Nephron Clin Pract; 2008; 110(2):c93-100. PubMed ID: 18815449
[TBL] [Abstract][Full Text] [Related]
7. Impact of hemodialysis, left ventricular mass and FGF-23 on myocardial mechanics in end-stage renal disease: a three-dimensional speckle tracking study.
Kovács A; Tapolyai M; Celeng C; Gara E; Faludi M; Berta K; Apor A; Nagy A; Tislér A; Merkely B
Int J Cardiovasc Imaging; 2014 Oct; 30(7):1331-7. PubMed ID: 25001896
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of brain natriuretic peptides and cardiac troponin in hemodialysis patients.
Resić H; Ajanović S; Kukavica N; Masnić F; Corić A
Bosn J Basic Med Sci; 2009 May; 9(2):137-41. PubMed ID: 19485946
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor is associated to left ventricular mass index, anemia and low values of transferrin saturation.
Eser B; Yayar O; Buyukbakkal M; Erdogan B; Ercan Z; Merhametsiz O; Haspulat A; Oğuz EG; Dogan İ; Canbakan B; Ayli MD
Nefrologia; 2015; 35(5):465-72. PubMed ID: 26394828
[TBL] [Abstract][Full Text] [Related]
10. The prognostic role of brain natriuretic peptides in hemodialysis patients.
Naganuma T; Sugimura K; Wada S; Yasumoto R; Sugimura T; Masuda C; Uchida J; Nakatani T
Am J Nephrol; 2002; 22(5-6):437-44. PubMed ID: 12381941
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis.
Seeherunvong W; Abitbol CL; Chandar J; Rusconi P; Zilleruelo GE; Freundlich M
Pediatr Nephrol; 2012 Nov; 27(11):2129-2136. PubMed ID: 22710695
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Increased Cardiac Troponin T in Patients with Chronic Hemodialysis and Cardiovascular Disease: Comparison to B-Type Natriuretic Peptide and A-Type Natriuretic Peptide Increase.
Niizuma S; Iwanaga Y; Washio T; Ashida T; Harasawa S; Miyazaki S; Matsumoto N
Kidney Blood Press Res; 2019; 44(5):1050-1062. PubMed ID: 31487705
[TBL] [Abstract][Full Text] [Related]
13. The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation.
Seiler S; Cremers B; Rebling NM; Hornof F; Jeken J; Kersting S; Steimle C; Ege P; Fehrenz M; Rogacev KS; Scheller B; Böhm M; Fliser D; Heine GH
Eur Heart J; 2011 Nov; 32(21):2688-96. PubMed ID: 21733911
[TBL] [Abstract][Full Text] [Related]
14. Effect of etelcalcetide on cardiac hypertrophy in hemodialysis patients: a randomized controlled trial (ETECAR-HD).
Dörr K; Kammer M; Reindl-Schwaighofer R; Lorenz M; Loewe C; Marculescu R; Erben R; Oberbauer R
Trials; 2019 Oct; 20(1):601. PubMed ID: 31651370
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration.
Milovanova LY; Dobrosmyslov IA; Milovanov YS; Taranova MV; Kozlov VV; Milovanova SY; Kozevnikova EI
Ter Arkh; 2018 Jun; 90(6):48-54. PubMed ID: 30701904
[TBL] [Abstract][Full Text] [Related]
16. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.
Cataliotti A; Malatino LS; Jougasaki M; Zoccali C; Castellino P; Giacone G; Bellanuova I; Tripepi R; Seminara G; Parlongo S; Stancanelli B; Bonanno G; Fatuzzo P; Rapisarda F; Belluardo P; Signorelli SS; Heublein DM; Lainchbury JG; Leskinen HK; Bailey KR; Redfield MM; Burnett JC
Mayo Clin Proc; 2001 Nov; 76(11):1111-9. PubMed ID: 11702899
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
[TBL] [Abstract][Full Text] [Related]
18. Role of fibroblast growth factor-23 in the pathogenesis of atherosclerosis in peritoneal dialysis patients.
Zeng Y; Feng S; Han OY; Shen HY; Jin DH; Shi YB
Genet Mol Res; 2015 Jan; 14(1):719-29. PubMed ID: 25730009
[TBL] [Abstract][Full Text] [Related]
19. Brain natriuretic peptide and its relationship to left ventricular hypertrophy in patients on peritoneal dialysis or hemodialysis less than 3 years.
Taskapan MC; Ulutas O; Aksoy Y; Senel S; Sahin I; Kosar F; Taskapan H
Ren Fail; 2006; 28(2):133-9. PubMed ID: 16538971
[TBL] [Abstract][Full Text] [Related]
20. Relationships Between Left Ventricular Structure and Function According to Cardiac MRI and Cardiac Biomarkers in End-Stage Renal Disease.
Ross BA; Wald R; Goldstein MB; Yuen DA; Leipsic J; Kiaii M; Rathe A; Deva DP; Kirpalani A; Bello OO; Graham JJ; Leong-Poi H; Connelly KA; Yan AT
Can J Cardiol; 2017 Apr; 33(4):501-507. PubMed ID: 28222921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
